Brief: Bioinvent Announces Clinical Trial Collaboration, Supply Agreement With MSD
02/04/2024 15:07
April 2 (Reuters) - BioInvent International AB
BINV.ST :
* ANNOUNCES A NEW CLINICAL TRIAL COLLABORATION AND SUPPLY
AGREEMENT WITH MSD TO EVALUATE BI-1910, THE COMPANY’S SECOND
ANTI-TNFR2 ANTIBODY IN COMBINATION WITH KEYTRUDA®
(PEMBROLIZUMAB)
* CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT WITH MSD
INTERNATIONAL BUSINESS GMBH, A SUBSIDIARY OF MERCK & CO., INC.
Source text for Eikon: ID:nMFN2LDHzy
Further company coverage: BINV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))